Longitude Venture Partners II, L.P.
Related Filers (13)
- Longitude Capital Partners II, LLC (14)
- Tammenoms Bakker Juliet (13)
- ENRIGHT PATRICK G (11)
- Aimmune Therapeutics, Inc. (4)
- Kala Pharmaceuticals, Inc. (2)
- Aptinyx Inc. (2)
- Tricida, Inc. (2)
- Vaxcyte, Inc. (2)
- RAPID MICRO BIOSYSTEMS, INC. (2)
- RxSight, Inc. (2)
- Venus Concept Inc. (1)
- Longitude Prime Partners, LLC (1)
- Longitude Prime Fund, L.P. (1)
- Show More ...
Other (5)
144
Tuesday, 11/28/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 11/14/2023
Filing for proposed sale of securities under Rule 144
D/A
Tuesday, 10/23/2012
Exempt (Private) Offering
D/A
Wednesday, 9/5/2012
Exempt (Private) Offering
D
Wednesday, 9/14/2011
Exempt (Private) Offering
Ownership (15)
SC 13G/A
Tuesday, 2/15/2022
Vaxcyte, Inc.: Major Shareholders
4
Tuesday, 7/20/2021
RAPID MICRO BIOSYSTEMS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/14/2021
RAPID MICRO BIOSYSTEMS, INC.: Initial statement of beneficial ownership of securities
3
Thursday, 6/11/2020
Vaxcyte, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 11/7/2019
Venus Concept Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/2/2018
Tricida, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/27/2018
Tricida, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/26/2018
Aptinyx Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/20/2018
Aptinyx Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/27/2017
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/19/2017
Kala Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/1/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/31/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/11/2015
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/5/2015
Aimmune Therapeutics, Inc.: Initial statement of beneficial ownership of securities